APOL1 inhibitor (GSK)

N/A

Report date: 2025/06/11 10:35:15
NME

Base Information

Drug NameAPOL1 inhibitor (GSK)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionApolipoprotein L1 inhibitors
TargetsApolipoprotein L1
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Llc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Llc
Inactive CompaniesN/A
Active IndicationsKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A